Nicky J. Willis
Gower Street, U.K
London, ENG WC1E6BT, United Kingdom
London, ENG WC1E6BT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity.
Journal: European journal of medicinal chemistry
Published: December 08, 2022
Large-scale synthesis of Notum inhibitor 1-(2,4-dichloro-3-(trifluoromethyl)-phenyl)-1H-1,2,3-triazole (ARUK3001185) employing a modified Sakai reaction as the key step.
Journal: RSC advances
Published: August 16, 2022
Structural Analysis and Development of Notum Fragment Screening Hits.
Journal: ACS chemical neuroscience
Published: June 22, 2022
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Journal: Journal of medicinal chemistry
Published: May 10, 2022
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Journal: Bioorganic & medicinal chemistry
Published: April 04, 2022
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.
Journal: Journal of medicinal chemistry
Published: December 23, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: Trichuris muris, Brugia malayi, Heligmosomoides polygyrus, and Schistosoma mansoni.
Journal: ACS infectious diseases
Published: April 02, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Journal: Journal of medicinal chemistry
Published: March 30, 2021
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy.
Journal: European journal of medicinal chemistry
Published: December 01, 2020
5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit.
Journal: Journal of medicinal chemistry
Published: October 30, 2020
Screening of a Custom-Designed Acid Fragment Library Identifies 1-Phenylpyrroles and 1-Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity.
Journal: Journal of medicinal chemistry
Published: August 14, 2020
NOTUM from Apc-mutant cells biases clonal competition to initiate cancer.
Journal: Nature
Published: March 05, 2020
Last Updated: 09/26/2026